GO:0060307 regulation of ventricular cardiac muscle cell membrane repolarization: Electrophysiology, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060307 describes the biological process that modulates the repolarization phase of the ventricular cardiomyocyte action potential, corresponding to the T wave on the electrocardiogram.
• Repolarization is driven by the coordinated activity of multiple ion channels, including voltage-gated sodium channels, potassium channels such as Kv11.1 (hERG), and Kir2.1, as well as the sodium-calcium exchanger.
• Dysregulation of ventricular repolarization is linked to arrhythmias, sudden cardiac death, and acquired or congenital long QT syndromes.
• The process is regulated by transcriptional, post-transcriptional, and non-transcriptional mechanisms, including hormonal modulation by testosterone.
• Experimental models for studying repolarization include single-cell voltage clamp, in silico electrophysiology simulations, and genetically modified animals.
• CRISPR-based gene editing enables precise knockout, point mutation, knock-in, and overexpression of repolarization-related genes to dissect their causal roles.
Description
Regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) is a fundamental biological process that governs the return of the ventricular cardiomyocyte membrane potential to its resting state after an action potential. This process is essential for normal cardiac excitation-contraction coupling and for the timing of the heartbeat, as it determines the duration of the action potential and the refractory period. At the whole-organ level, ventricular repolarization is reflected by the T wave on the electrocardiogram, and abnormalities in this process are associated with life-threatening arrhythmias. Understanding the molecular and cellular mechanisms that regulate repolarization is therefore critical for both basic cardiac electrophysiology and translational research into arrhythmia syndromes. The repolarization phase of the ventricular action potential is orchestrated by a delicate balance of inward and outward ionic currents. Voltage-gated sodium channels contribute to the initial depolarization and early repolarization, while various potassium channels, including Kv11.1 (hERG) and Kir2.1, mediate the outward currents that drive repolarization. Additionally, the sodium-calcium exchanger influences membrane potential and contraction-relaxation dynamics. These ion channels and transporters are subject to multiple levels of regulation, including transcriptional control, post-translational modifications, and non-transcriptional modulation by hormones such as testosterone. Given the complexity of repolarization, researchers employ a range of experimental approaches, from single-cell voltage clamp to in silico modeling, to dissect the contributions of individual components. The advent of CRISPR gene editing has further empowered the creation of isogenic cell and animal models carrying precise genetic alterations in repolarization-related genes, enabling causal inference and drug testing. This article provides a comprehensive overview of GO:0060307, covering its definition, molecular players, disease relevance, and state-of-the-art research methodologies.
regulation of ventricular cardiac muscle cell membrane repolarization At A Glance
| GO ID | GO:0060307 |
|---|---|
| GO term | regulation of ventricular cardiac muscle cell membrane repolarization |
| Ontology | biological_process |
| Synonym | electrocardiogram T wave; regulation of ventricular cardiac muscle cell repolarization; regulation of ventricular cardiac muscle repolarization; regulation of ventricular cardiomyocyte membrane repolarization; ventricular repolarization |
| Major function | Modulates the return of the ventricular cardiomyocyte membrane potential to resting state after an action potential, shaping the action potential duration and refractory period. |
| Key ion channels | Voltage-gated sodium channels (e.g., Nav1.5), potassium channels (e.g., Kv11.1/hERG, Kir2.1), and the sodium-calcium exchanger. |
| Cellular location | Sarcolemma (plasma membrane) of ventricular cardiomyocytes. |
| Physiological readout | Electrocardiogram T wave; action potential duration; QT interval. |
| Related disease | Long QT syndrome, short QT syndrome, Brugada syndrome, arrhythmogenic right ventricular cardiomyopathy. |
What Is GO:0060307?
GO:0060307, regulation of ventricular cardiac muscle cell membrane repolarization, is defined as any process that modulates the establishment or extent of a membrane potential in the polarizing direction towards the resting potential in a ventricular cardiomyocyte. In simpler terms, it encompasses all the cellular mechanisms that control how the ventricular heart muscle cell electrically resets after each beat, ensuring the cell is ready for the next contraction.
Why Is regulation of ventricular cardiac muscle cell membrane repolarization Important in Cell Biology?
Regulation of ventricular repolarization is critical because it determines the duration of the action potential and the refractory period, directly influencing cardiac rhythm and contractility. Disruptions in this process can lead to early afterdepolarizations, re-entrant arrhythmias, and sudden cardiac death. Moreover, many pharmacological agents inadvertently affect repolarization, making it a key safety concern in drug development. Thus, understanding GO:0060307 is essential for both fundamental cardiac biology and clinical translation.
• Determines action potential duration and QT interval on the ECG.
• Dysregulation causes long QT syndrome and torsades de pointes.
• Influences cardiac contractility by modulating calcium handling.
• Target of pharmacological safety testing (hERG trafficking).
• Modulated by hormones such as testosterone.
• Involves trafficking of ion channels to the membrane.
• Genetic variants in repolarization genes are linked to sudden death.
• Provides a model for studying membrane potential regulation.
• Key for understanding sex differences in arrhythmia risk.
• Enables development of precision therapies for channelopathies.
What Happens During regulation of ventricular cardiac muscle cell membrane repolarization?
Phase 0: Depolarization and Sodium Channel Inactivation
In simple terms: The cell rapidly becomes positive inside due to sodium influx, then sodium channels close to prepare for resetting.
The ventricular action potential begins with a rapid depolarization driven by voltage-gated sodium channels, primarily Nav1.5. These channels open in response to membrane depolarization, allowing a large influx of sodium ions. Their subsequent inactivation is a critical determinant of the early repolarization phase and is regulated by multiple mechanisms, including the channel's intrinsic inactivation gate and auxiliary subunits. Defects in sodium channel inactivation can lead to persistent sodium current, prolonging repolarization and increasing arrhythmia risk.
Phase 1 and 2: Early Repolarization and Plateau
In simple terms: Some potassium leaves the cell while calcium enters, creating a balance that keeps the cell depolarized for a while.
Following depolarization, transient outward potassium currents (Ito) cause early repolarization (Phase 1). The plateau phase (Phase 2) is maintained by a balance between inward calcium currents (ICa-L) and outward potassium currents. The sodium-calcium exchanger also contributes to the plateau and to contraction-relaxation coupling. During this phase, the membrane potential is relatively stable, and the cell is refractory to new action potentials.
Phase 3: Repolarization and Potassium Currents
In simple terms: Potassium flows out of the cell, bringing the voltage back down to the resting level.
The repolarization phase (Phase 3) is primarily driven by the activation of delayed rectifier potassium currents, including IKr (Kv11.1/hERG) and IKs, as well as the inward rectifier current IK1 (Kir2.1). Kv11.1 channel trafficking and function are dynamically regulated, and in silico models have highlighted the importance of these processes for action potential duration. Kir2.1 sets the resting membrane potential and contributes to the final phase of repolarization. The coordinated activity of these channels ensures timely return to the resting state.
Phase 4: Resting Potential and Sodium-Calcium Exchange
In simple terms: The cell returns to its resting voltage, and the sodium-calcium exchanger helps maintain calcium balance.
During diastole (Phase 4), the membrane potential is maintained near the potassium equilibrium potential by inward rectifier potassium channels (Kir2.1). The sodium-calcium exchanger (NCX) continues to extrude calcium in exchange for sodium, influencing both membrane potential and relaxation. Regulation of NCX activity is important for preventing calcium overload and arrhythmias. The resting potential is also modulated by other transporters and channels, ensuring the cell is ready for the next excitation.
Regulation by Non-Transcriptional Mechanisms
In simple terms: Hormones and other signals can quickly change how the cell repolarizes without altering gene expression.
Beyond transcriptional control, repolarization currents are subject to rapid, non-transcriptional regulation. For example, testosterone acutely modulates cardiac repolarization currents, potentially explaining sex differences in arrhythmia susceptibility. Additionally, trafficking of ion channels to and from the membrane, such as Kv11.1 and connexin 43, can dynamically alter repolarization capacity. These regulatory mechanisms allow the heart to adapt to physiological demands and are potential targets for therapeutic intervention.
Key Genes Involved in GO:0060307 regulation of ventricular cardiac muscle cell membrane repolarization
The following genes encode ion channels, transporters, and regulatory proteins that are central to the regulation of ventricular cardiac muscle cell membrane repolarization.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCN5A | Encodes Nav1.5, the primary cardiac voltage-gated sodium channel; inactivation contributes to early repolarization. | Mutations cause Brugada syndrome and long QT syndrome; target for antiarrhythmic drugs. |
| KCNH2 | Encodes Kv11.1 (hERG), a delayed rectifier potassium channel mediating IKr. | Mutations cause long QT syndrome type 2; hERG trafficking is a drug safety concern. |
| KCNQ1 | Encodes Kv7.1, which with KCNE1 forms the IKs channel. | Mutations cause long QT syndrome type 1 and short QT syndrome; important for repolarization reserve. |
| KCNJ2 | Encodes Kir2.1, the inward rectifier potassium channel responsible for IK1. | Mutations cause Andersen-Tawil syndrome and short QT syndrome; regulates resting potential. |
| KCNE1 | Encodes MinK, a beta subunit that modulates Kv7.1 and other channels. | Mutations cause long QT syndrome type 5 and Jervell and Lange-Nielsen syndrome. |
| KCNE2 | Encodes MiRP1, a beta subunit that modulates hERG and other channels. | Mutations associated with long QT syndrome and drug-induced arrhythmias. |
| CACNA1C | Encodes Cav1.2, the alpha-1C subunit of L-type calcium channels. | Mutations cause Timothy syndrome and Brugada syndrome; contributes to plateau phase. |
| SCN1B | Encodes a sodium channel beta-1 subunit that modulates Nav1.5 gating. | Mutations linked to Brugada syndrome and epilepsy; affects inactivation. |
| SCN2B | Encodes a sodium channel beta-2 subunit that modulates Nav1.5. | Mutations may alter repolarization and arrhythmia susceptibility. |
| SLC8A1 | Encodes the sodium-calcium exchanger NCX1. | Regulates calcium and membrane potential; involved in arrhythmias and heart failure. |
| ATP2A2 | Encodes SERCA2, the sarcoplasmic reticulum calcium ATPase. | Affects calcium handling and contraction-relaxation; mutations cause Darier disease. |
| RYR2 | Encodes the ryanodine receptor 2, a calcium release channel. | Mutations cause catecholaminergic polymorphic ventricular tachycardia; influences repolarization. |
| GJA1 | Encodes connexin 43, a gap junction protein. | Regulates impulse propagation and repolarization; trafficking affects arrhythmogenesis. |
| FGF13 | Encodes fibroblast growth factor 13, a microtubule-stabilizing protein. | Regulates sodium channel trafficking and impulse propagation; knockout alters repolarization. |
| ANK2 | Encodes ankyrin-B, a cytoskeletal adaptor protein. | Mutations cause long QT syndrome type 4 and arrhythmia; targets ion channels to membrane. |
| CAV3 | Encodes caveolin-3, a membrane scaffolding protein. | Mutations cause long QT syndrome type 9; regulates ion channel localization. |
| SNTA1 | Encodes alpha-1-syntrophin, a scaffold protein. | Mutations linked to long QT syndrome; modulates Nav1.5 and other channels. |
| PKP2 | Encodes plakophilin-2, a desmosomal protein. | Mutations cause arrhythmogenic right ventricular cardiomyopathy; affects sodium current. |
How Is regulation of ventricular cardiac muscle cell membrane repolarization Regulated?
The process of ventricular repolarization is regulated at multiple levels. Transcriptionally, the expression of ion channel genes such as KCNH2, KCNQ1, and SCN5A is controlled by cardiac transcription factors and can be altered in disease. Post-transcriptionally, microRNAs and RNA-binding proteins modulate channel mRNA stability and translation. Non-transcriptional regulation includes acute modulation by hormones (e.g., testosterone), phosphorylation by kinases, and trafficking of channels to and from the membrane. For instance, Kv11.1 trafficking is dynamically regulated, and in silico models show that altered trafficking significantly impacts action potential duration. Similarly, FGF13 regulates sodium channel trafficking and gap junction function, influencing repolarization and impulse propagation. These regulatory layers ensure fine-tuning of repolarization under physiological conditions and contribute to arrhythmogenesis when disrupted.
regulation of ventricular cardiac muscle cell membrane repolarization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNH2 | Long QT syndrome type 2; drug-induced arrhythmia | Knockout or point mutation in hiPSC-derived cardiomyocytes; overexpression of mutant hERG |
| SCN5A | Brugada syndrome; long QT syndrome type 3 | Knock-in of SCN5A mutations in hiPSCs; knockout in zebrafish |
| KCNJ2 | Andersen-Tawil syndrome; short QT syndrome | Knockout mice; overexpression of Kir2.1 mutants in cardiomyocytes |
| SLC8A1 | Heart failure; arrhythmia | Cardiomyocyte-specific knockout; overexpression of NCX1 |
| FGF13 | Arrhythmia; impulse propagation defects | Knockout mice; knockdown in hiPSC-cardiomyocytes |
Long QT Syndrome and Arrhythmias
Long QT syndrome (LQTS) is a disorder characterized by prolonged ventricular repolarization, manifesting as a prolonged QT interval on the ECG and increased risk of torsades de pointes and sudden cardiac death. Mutations in genes encoding repolarization currents, such as KCNH2 (LQTS2), KCNQ1 (LQTS1), and SCN5A (LQTS3), are well-established causes. Additionally, acquired LQTS can result from drug-induced blockade of hERG trafficking or function. Understanding the regulation of repolarization is thus critical for diagnosing and managing these conditions.
Short QT Syndrome and Brugada Syndrome
Short QT syndrome (SQTS) is a rare inherited arrhythmia syndrome characterized by abbreviated repolarization and increased risk of atrial and ventricular fibrillation. Gain-of-function mutations in potassium channels such as KCNH2, KCNQ1, and KCNJ2 have been implicated. Brugada syndrome, on the other hand, is linked to loss-of-function mutations in SCN5A and other genes, leading to abnormal repolarization and ST-segment elevation. These channelopathies highlight the delicate balance required for normal repolarization.
Heart Failure and Remodeling
In heart failure, electrical remodeling occurs, including changes in ion channel expression and function that prolong repolarization and increase arrhythmia risk. Downregulation of potassium currents (e.g., Ito, IKr, IKs) and alterations in calcium handling contribute to action potential prolongation. The sodium-calcium exchanger is also upregulated in heart failure, affecting both calcium homeostasis and membrane potential. These changes underscore the importance of repolarization regulation in cardiac disease progression.
Sex Differences and Hormonal Modulation
Epidemiological studies show that women have a longer QT interval and higher risk of drug-induced torsades de pointes compared to men. Testosterone has been shown to acutely modulate cardiac repolarization currents, providing a mechanistic basis for these sex differences. This non-transcriptional regulation highlights the complexity of repolarization control and its clinical implications.
From regulation of ventricular cardiac muscle cell membrane repolarization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene alter action potential duration? | CRISPR knockout in hiPSC-derived cardiomyocytes or mouse models |
| Does a specific point mutation in an ion channel cause repolarization defects? | CRISPR point mutation knock-in in hiPSCs or animal models |
| How does a disease-associated variant affect channel trafficking? | Knock-in of tagged channel (e.g., GFP) followed by live imaging |
| Can overexpression of a potassium channel shorten repolarization? | CRISPR-mediated overexpression in cardiomyocytes |
| What is the role of a non-coding variant in repolarization? | CRISPR interference or activation screens in hiPSC-cardiomyocytes |
| Does a drug affect repolarization via a specific channel? | Isogenic knockout of the channel followed by drug testing |
How to Study the regulation of ventricular cardiac muscle cell membrane repolarization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch clamp | Ion currents and action potentials | Characterize repolarization defects in edited cardiomyocytes |
| In silico modeling | Simulated action potential and ion currents | Predict effects of channel trafficking or mutations |
| Optical mapping | Spatial and temporal repolarization patterns | Assess arrhythmia susceptibility in edited hearts |
| RNA-seq | Transcriptional changes | Identify gene expression changes after CRISPR editing |
| Proteomics | Protein expression and modifications | Quantify ion channel proteins and post-translational modifications |
| Live-cell imaging | Channel trafficking and localization | Track tagged channels in edited cells |
| CRISPR screen | Gene function at scale | Discover novel repolarization regulators |
Patch Clamp Electrophysiology
Single-cell voltage clamp is the gold standard for measuring ion currents and action potentials in cardiomyocytes. It allows precise characterization of repolarization currents, such as IKr, IKs, and IK1, and can be used to assess the effects of genetic modifications or drugs. When combined with CRISPR-edited cells, patch clamp provides direct causal evidence for the role of specific genes in repolarization.
In Silico Modeling
Computational models of the cardiac action potential integrate ion channel kinetics and can simulate repolarization under various conditions. These models are particularly useful for understanding the dynamic regulation of ion channels, such as Kv11.1 trafficking, and for predicting arrhythmia risk. In silico analysis can guide experimental design and interpret complex data.
Optical Mapping and Voltage-Sensitive Dyes
Optical mapping using voltage-sensitive dyes enables simultaneous recording of action potentials from multiple cells or whole hearts, providing spatial information about repolarization dispersion. This technique is valuable for studying arrhythmia mechanisms and the effects of gene editing on repolarization heterogeneity.
CRISPR Screening and Transcriptomics
Pooled CRISPR screens combined with RNA sequencing can identify genes that regulate repolarization when knocked out or overexpressed. This unbiased approach can uncover novel regulators and pathways. Bioinformatics analysis of transcriptomic data from edited cardiomyocytes can reveal changes in ion channel expression networks.
How CRISPR Can Be Used to Study GO:0060307 regulation of ventricular cardiac muscle cell membrane repolarization
Knockout
CRISPR knockout of repolarization-related genes, such as KCNH2 or SCN5A, in hiPSC-derived cardiomyocytes or animal models allows researchers to assess the loss-of-function consequences on action potential duration and arrhythmia susceptibility. For example, knockout of FGF13 in mice altered sodium channel trafficking and impulse propagation, demonstrating its role in repolarization.
Point Mutation
Introducing disease-associated point mutations (e.g., KCNH2 A561V, SCN5A R1644H) via CRISPR base editing or homology-directed repair creates isogenic models to study the specific effects of variants on channel function and repolarization. These models are invaluable for understanding genotype-phenotype relationships and testing personalized therapies.
Knock-in
Knock-in of reporter tags (e.g., GFP) or epitope tags into endogenous ion channel genes enables real-time tracking of channel trafficking and localization. This approach has been used to study Kv11.1 trafficking and its regulation by drugs or genetic modifiers. Knock-in of human disease mutations into animal models also provides physiologically relevant systems.
Overexpression
CRISPR-mediated overexpression of ion channels or regulatory proteins (e.g., KCNQ1, KCNE1) can enhance repolarization currents and shorten action potential duration. This is useful for gain-of-function studies and for testing whether increasing a specific current can rescue repolarization defects. Overexpression models also help identify rate-limiting components of repolarization.
How EDITGENE Supports regulation of ventricular cardiac muscle cell membrane repolarization Research
Researchers studying regulation of ventricular cardiac muscle cell membrane repolarization-related genes often need to determine whether a candidate gene is causally involved in repolarization and to dissect its mechanism of action. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of ventricular cardiac muscle cell membrane repolarization research.
Frequently Asked Questions About regulation of ventricular cardiac muscle cell membrane repolarization
What is GO:0060307?
GO:0060307 is the Gene Ontology term for regulation of ventricular cardiac muscle cell membrane repolarization, the process that controls the return of the ventricular cardiomyocyte membrane potential to its resting state after an action potential.
What genes are involved in ventricular repolarization?
Key genes include SCN5A, KCNH2, KCNQ1, KCNJ2, KCNE1, CACNA1C, SLC8A1, and FGF13, among others.
How is ventricular repolarization regulated?
It is regulated by transcriptional, post-transcriptional, and non-transcriptional mechanisms, including hormonal modulation by testosterone and trafficking of ion channels.
What diseases are associated with abnormal repolarization?
Long QT syndrome, short QT syndrome, Brugada syndrome, and heart failure are associated with repolarization abnormalities.
What is the role of hERG in repolarization?
hERG (Kv11.1) mediates the rapid delayed rectifier potassium current (IKr), which is crucial for phase 3 repolarization; mutations cause long QT syndrome type 2.
How can CRISPR help study repolarization?
CRISPR enables knockout, point mutation, knock-in, and overexpression of repolarization genes in cardiomyocyte models, allowing causal testing of gene function.
What methods are used to measure repolarization?
Patch clamp electrophysiology, optical mapping, in silico modeling, and ECG are commonly used.
What is the T wave on an ECG?
The T wave represents ventricular repolarization; its duration and shape reflect the underlying repolarization process.
Can sex hormones affect repolarization?
Yes, testosterone acutely modulates cardiac repolarization currents, contributing to sex differences in arrhythmia risk.
What is the sodium-calcium exchanger's role in repolarization?
NCX influences membrane potential and calcium handling during the plateau and resting phases, affecting repolarization and contraction.
Conclusion
Regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) is a complex and finely tuned biological process essential for normal cardiac function. Dysregulation of this process underlies a spectrum of arrhythmia syndromes and contributes to heart failure. Advances in CRISPR gene editing and electrophysiological techniques are enabling researchers to dissect the causal roles of individual genes and variants, paving the way for precision medicine approaches. EDITGENE's comprehensive services support these efforts by providing custom-engineered models and bioinformatics solutions.
References
- 1. Das LT et al.. 2025. FGF13 Regulates VGSC-Independent Cardiomyocyte Impulse Propagation via Cx43 Trafficking.. Circ Res 137(12):1522-1539 PMID: 41200819
- 2. Bai CX et al.. 2005. Nontranscriptional regulation of cardiac repolarization currents by testosterone.. Circulation 112(12):1701-10 PMID: 16157773
- 3. Mangold KE et al.. 2017. Mechanisms and models of cardiac sodium channel inactivation.. Channels (Austin) 11(6):517-533 PMID: 28837385
- 4. Meier S et al.. 2023. In silico analysis of the dynamic regulation of cardiac electrophysiology by K(v) 11.1 ion-channel trafficking.. J Physiol 601(13):2711-2731 PMID: 36752166
- 5. Bouchard RA et al.. 1993. Regulation of unloaded cell shortening by sarcolemmal sodium-calcium exchange in isolated rat ventricular myocytes.. J Physiol 469:583-99 PMID: 8271217
- 6. Varró A et al.. 1992. The impact of single cell voltage clamp on the understanding of the cardiac ventricular action potential.. Cardioscience 3(3):131-44 PMID: 1384746
- 7. Li E et al.. 2024. The network of cardiac K(IR)2.1: its function, cellular regulation, electrical signaling, diseases and new drug avenues.. Naunyn Schmiedebergs Arch Pharmacol 397(9):6369-6389 PMID: 38683369
- 8. Ferrier GR et al.. 2000. Regulation of contraction and relaxation by membrane potential in cardiac ventricular myocytes.. Am J Physiol Heart Circ Physiol 278(5):H1618-26 PMID: 10775142
